These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


253 related items for PubMed ID: 30830950

  • 1. Class I histone deacetylase inhibitor MS-275 attenuates vasoconstriction and inflammation in angiotensin II-induced hypertension.
    Ryu Y, Kee HJ, Sun S, Seok YM, Choi SY, Kim GR, Kee SJ, Pflieger M, Kurz T, Kim HS, Jeong MH.
    PLoS One; 2019; 14(3):e0213186. PubMed ID: 30830950
    [Abstract] [Full Text] [Related]

  • 2. Histone deacetylase inhibitor LMK235 attenuates vascular constriction and aortic remodelling in hypertension.
    Choi SY, Kee HJ, Sun S, Seok YM, Ryu Y, Kim GR, Kee SJ, Pflieger M, Kurz T, Kassack MU, Jeong MH.
    J Cell Mol Med; 2019 Apr; 23(4):2801-2812. PubMed ID: 30734467
    [Abstract] [Full Text] [Related]

  • 3. HDAC5 inhibition reduces angiotensin II-induced vascular contraction, hypertrophy, and oxidative stress in a mouse model.
    Bai L, Kee HJ, Choi SY, Seok YM, Kim GR, Kee SJ, Kook H, Jeong MH.
    Biomed Pharmacother; 2021 Feb; 134():111162. PubMed ID: 33360932
    [Abstract] [Full Text] [Related]

  • 4. Exercise training attenuates angiotensin II-induced vasoconstriction in the aorta of normotensive but not hypertensive rats.
    Oliveira PR, Oliveira PB, Rossignoli PS, Spadella MA, Chies AB.
    Exp Physiol; 2020 Apr; 105(4):732-742. PubMed ID: 31999028
    [Abstract] [Full Text] [Related]

  • 5. Fibroblast Nox2 (NADPH Oxidase-2) Regulates ANG II (Angiotensin II)-Induced Vascular Remodeling and Hypertension via Paracrine Signaling to Vascular Smooth Muscle Cells.
    Harrison CB, Trevelin SC, Richards DA, Santos CXC, Sawyer G, Markovinovic A, Zhang X, Zhang M, Brewer AC, Yin X, Mayr M, Shah AM.
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):698-710. PubMed ID: 33054395
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhibiting histone deacetylase 1 suppresses both inflammation and bone loss in arthritis.
    Cantley MD, Fairlie DP, Bartold PM, Marino V, Gupta PK, Haynes DR.
    Rheumatology (Oxford); 2015 Sep; 54(9):1713-23. PubMed ID: 25832610
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Angiotensin II enhances endothelin-1-induced vasoconstriction through upregulating endothelin type A receptor.
    Lin YJ, Kwok CF, Juan CC, Hsu YP, Shih KC, Chen CC, Ho LT.
    Biochem Biophys Res Commun; 2014 Aug 22; 451(2):263-9. PubMed ID: 25088996
    [Abstract] [Full Text] [Related]

  • 11. The renin-angiotensin system and its vasoactive metabolite angiotensin-(1-7) in the mechanism of the healing of preexisting gastric ulcers. The involvement of Mas receptors, nitric oxide, prostaglandins and proinflammatory cytokines.
    Pawlik MW, Kwiecien S, Ptak-Belowska A, Pajdo R, Olszanecki R, Suski M, Madej J, Targosz A, Konturek SJ, Korbut R, Brzozowski T.
    J Physiol Pharmacol; 2016 Feb 22; 67(1):75-91. PubMed ID: 27010897
    [Abstract] [Full Text] [Related]

  • 12. Selective inhibition of histone deacetylase 8 improves vascular hypertrophy, relaxation, and inflammation in angiotensin II hypertensive mice.
    Kee HJ, Ryu Y, Seok YM, Choi SY, Sun S, Kim GR, Jeong MH.
    Clin Hypertens; 2019 Feb 22; 25():13. PubMed ID: 31223486
    [Abstract] [Full Text] [Related]

  • 13. Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling.
    Ishibashi M, Hiasa K, Zhao Q, Inoue S, Ohtani K, Kitamoto S, Tsuchihashi M, Sugaya T, Charo IF, Kura S, Tsuzuki T, Ishibashi T, Takeshita A, Egashira K.
    Circ Res; 2004 May 14; 94(9):1203-10. PubMed ID: 15059935
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin II type 1A receptors in vascular smooth muscle cells do not influence aortic remodeling in hypertension.
    Sparks MA, Parsons KK, Stegbauer J, Gurley SB, Vivekanandan-Giri A, Fortner CN, Snouwaert J, Raasch EW, Griffiths RC, Haystead TA, Le TH, Pennathur S, Koller B, Coffman TM.
    Hypertension; 2011 Mar 14; 57(3):577-85. PubMed ID: 21242463
    [Abstract] [Full Text] [Related]

  • 15. BCL6 Attenuates Proliferation and Oxidative Stress of Vascular Smooth Muscle Cells in Hypertension.
    Chen D, Zang YH, Qiu Y, Zhang F, Chen AD, Wang JJ, Chen Q, Li YH, Kang YM, Zhu GQ.
    Oxid Med Cell Longev; 2019 Mar 14; 2019():5018410. PubMed ID: 30805081
    [Abstract] [Full Text] [Related]

  • 16. The inhibitory effect of leptin on angiotensin II-induced vasoconstriction in vascular smooth muscle cells is mediated via a nitric oxide-dependent mechanism.
    Rodríguez A, Fortuño A, Gómez-Ambrosi J, Zalba G, Díez J, Frühbeck G.
    Endocrinology; 2007 Jan 14; 148(1):324-31. PubMed ID: 17038553
    [Abstract] [Full Text] [Related]

  • 17. Connexin37-Dependent Mechanisms Selectively Contribute to Modulate Angiotensin II -Mediated Hypertension.
    Le Gal L, Pellegrin M, Santoro T, Mazzolai L, Kurtz A, Meda P, Wagner C, Haefliger JA.
    J Am Heart Assoc; 2019 Apr 16; 8(8):e010823. PubMed ID: 30943815
    [Abstract] [Full Text] [Related]

  • 18. Sex differences and role of lysyl oxidase-like 2 in angiotensin II-induced hypertension in mice.
    Wang H, Martinez Yus M, Brady T, Choi R, Nandakumar K, Smith L, Jang R, Wodu BP, Almodiel JD, Stoddart L, Kim DH, Steppan J, Santhanam L.
    Am J Physiol Heart Circ Physiol; 2024 Sep 01; 327(3):H642-H659. PubMed ID: 39028284
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.